85 related articles for article (PubMed ID: 9568121)
1. Glycosylated antitumor ether lipids are more effective against oncogene-transformed fibroblasts than alkyllysophospholipids.
Samadder P; Byun HS; Bittman R; Arthur G
Anticancer Res; 1998; 18(1A):465-70. PubMed ID: 9568121
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of the antiproliferative effects of 1-O-hexadecyl-2-O-methyl-3-O-(2'-acetamido-2'-deoxy-beta-D- glucopyranosyl)-sn-glycerol and 1-O-hexadecyl-2-O-methyl-3-0- (2'-amino-2'-deoxy-beta-D-glucopyranosyl)-sn-glycerol on epithelial cancer cell growth.
Erukulla RK; Zhou X; Samadder P; Arthur G; Bittman R
J Med Chem; 1996 Mar; 39(7):1545-8. PubMed ID: 8691486
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of protein kinase C by ether-linked lipids is not correlated with their antineoplastic activity on WEHI-3B and R6X-B15 cells.
Salari H; Dryden P; Davenport R; Howard S; Jones K; Bittman R
Biochim Biophys Acta; 1992 Feb; 1134(1):81-8. PubMed ID: 1543759
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
Powis G; Seewald MJ; Gratas C; Melder D; Riebow J; Modest EJ
Cancer Res; 1992 May; 52(10):2835-40. PubMed ID: 1316230
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
Marino-Albernas JR; Bittman R; Peters A; Mayhew E
J Med Chem; 1996 Aug; 39(17):3241-7. PubMed ID: 8765506
[TBL] [Abstract][Full Text] [Related]
6. An active endocytosis pathway is required for the cytotoxic effects of glycosylated antitumor ether lipids.
Samadder P; Byun HS; Bittman R; Arthur G
Anticancer Res; 2011 Nov; 31(11):3809-18. PubMed ID: 22110203
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues.
Berggren MI; Gallegos A; Dressler LA; Modest EJ; Powis G
Cancer Res; 1993 Sep; 53(18):4297-302. PubMed ID: 8395981
[TBL] [Abstract][Full Text] [Related]
8. Enantioselective synthesis and antiproliferative properties of an ilmofosine analog, 2'-(trimethylammonio)ethyl 3-(hexadecyloxy)-2-(methoxymethyl)propyl phosphate, on epithelial cancer cell growth.
Bittman R; Byun HS; Reddy KC; Samadder P; Arthur G
J Med Chem; 1997 Apr; 40(9):1391-5. PubMed ID: 9135036
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.
Seewald MJ; Olsen RA; Sehgal I; Melder DC; Modest EJ; Powis G
Cancer Res; 1990 Aug; 50(15):4458-63. PubMed ID: 2369723
[TBL] [Abstract][Full Text] [Related]
10. The antitumor ether lipid 1-Q-octadecyl-2-O-methyl-rac-glycerophosphocholine (ET-18-OCH3) inhibits the association between Ras and Raf-1.
Samadder P; Richards C; Bittman R; Bhullar RP; Arthur G
Anticancer Res; 2003; 23(3B):2291-5. PubMed ID: 12894505
[TBL] [Abstract][Full Text] [Related]
11. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Chabot MC; Wykle RL; Modest EJ; Daniel LW
Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
[TBL] [Abstract][Full Text] [Related]
12. 1-O-octadecyl-2-O-methyl-glycerophosphocholine inhibits the transduction of growth signals via the MAPK cascade in cultured MCF-7 cells.
Zhou X; Lu X; Richard C; Xiong W; Litchfield DW; Bittman R; Arthur G
J Clin Invest; 1996 Aug; 98(4):937-44. PubMed ID: 8770865
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of ether-linked analogues of lysophosphatidate and their effect on the proliferation of human epithelial cancer cells in vitro.
Ashagbley A; Samadder P; Bittman R; Erukulla RK; Byun HS; Arthur G
Anticancer Res; 1996; 16(4A):1813-8. PubMed ID: 8712705
[TBL] [Abstract][Full Text] [Related]
14. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M
Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic properties of D-gluco-, D-galacto- and D-manno-configured 2-amino-2-deoxy-glycerolipids against epithelial cancer cell lines and BT-474 breast cancer stem cells.
Samadder P; Xu Y; Schweizer F; Arthur G
Eur J Med Chem; 2014 May; 78():225-35. PubMed ID: 24681987
[TBL] [Abstract][Full Text] [Related]
16. Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes.
Samadder P; Arthur G
Cancer Res; 1999 Oct; 59(19):4808-15. PubMed ID: 10519389
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activity of ether glycerophospholipids bearing a carbamate moiety at the sn-2 position: selective sensitivity against prostate cancer cell lines.
Byun HS; Bittman R; Samadder P; Arthur G
ChemMedChem; 2010 Jul; 5(7):1045-52. PubMed ID: 20533503
[TBL] [Abstract][Full Text] [Related]
18. Aberrations in interleukin-1 expression in oncogene-transformed fibrosarcoma lines: constitutive interleukin-1 alpha transcription and manifestation of biological activity.
Douvdevani A; Huleihel M; Segal S; Apte RN
Eur Cytokine Netw; 1991; 2(4):257-64. PubMed ID: 1756231
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
Unger C; Eibl H; Kim DJ; Fleer EA; Kötting J; Bartsch HH; Nagel GA; Pfizenmaier K
J Natl Cancer Inst; 1987 Feb; 78(2):219-22. PubMed ID: 3468284
[TBL] [Abstract][Full Text] [Related]
20. Glycosylated antitumor ether lipids: activity and mechanism of action.
Arthur G; Bittman R
Anticancer Agents Med Chem; 2014 May; 14(4):592-606. PubMed ID: 24628233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
